Apyx Medical (NASDAQ:APYX) Upgraded to “Strong-Buy” by Craig Hallum

Craig Hallum upgraded shares of Apyx Medical (NASDAQ:APYX) to a strong-buy rating in a research report report published on Thursday morning, Zacks.com reports.

Several other equities analysts have also recently commented on APYX. JMP Securities reissued a “market perform” rating on shares of Apyx Medical in a research note on Monday, September 16th. BTIG Research assumed coverage on Apyx Medical in a report on Thursday, October 17th. They set a “neutral” rating on the stock.

Apyx Medical Stock Up 10.0 %

NASDAQ:APYX opened at $1.21 on Thursday. The company has a debt-to-equity ratio of 2.26, a quick ratio of 4.45 and a current ratio of 5.33. The company has a market capitalization of $41.92 million, a price-to-earnings ratio of -1.83 and a beta of 1.20. Apyx Medical has a one year low of $0.97 and a one year high of $3.26. The stock has a 50-day simple moving average of $1.22 and a 200 day simple moving average of $1.34.

Apyx Medical (NASDAQ:APYX) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The firm had revenue of $12.15 million for the quarter, compared to analyst estimates of $12.67 million. During the same period in the prior year, the company posted ($0.11) earnings per share. Sell-side analysts predict that Apyx Medical will post -0.7 EPS for the current fiscal year.

Hedge Funds Weigh In On Apyx Medical

A number of institutional investors have recently made changes to their positions in the business. Commonwealth Equity Services LLC bought a new stake in shares of Apyx Medical in the 1st quarter worth approximately $676,000. Rathbones Group PLC lifted its position in Apyx Medical by 148.0% in the second quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after purchasing an additional 150,000 shares during the period. RPg Family Wealth Advisory LLC acquired a new stake in Apyx Medical during the second quarter worth $101,000. Kingsview Wealth Management LLC raised its stake in shares of Apyx Medical by 156.7% in the 1st quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock valued at $42,000 after buying an additional 18,943 shares in the last quarter. Finally, Perkins Capital Management Inc. lifted its holdings in shares of Apyx Medical by 7.0% during the 1st quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after acquiring an additional 15,000 shares during the period. 55.33% of the stock is currently owned by institutional investors.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.